Morgan Stanley Maintains Equal-Weight on Alteryx, Lowers Price Target to $81
Morgan Stanley maintains Alteryx (NYSE:AYX) with a Equal-Weight and lowers the price target from $89 to $81.
Needham Maintains Buy on Alteryx, Lowers Price Target to $66
Needham analyst Mike Cikos maintains Alteryx (NYSE:AYX) with a Buy and lowers the price target from $97 to $66.
Piper Sandler Maintains Overweight on Alteryx, Raises Price Target to $87
Piper Sandler maintains Alteryx (NYSE:AYX) with a Overweight and raises the price target from $85 to $87.
Why Alteryx Shares Are Rising In Tuesday’s After-Hours Session
Alteryx Inc (NYSE: AYX) shares are trading higher by 6.3% at $55.50 during Tuesday's after-hours session after the company reported better-than-expected fourth-quarter EPS results.
Alteryx Earnings Preview
Alteryx (NYSE:AYX) is set to give its latest quarterly earnings report on Tuesday, 2022-02-15. Here's what investors need to know before the announcement.
Analysts estimate that Alteryx will report an earnings per share (EPS) of $0.05.
10 Biggest Price Target Changes For Tuesday
Baird cut the price target on Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) from $24 to $11. Tabula Rasa HealthCare shares fell 2% to $10.57 in pre-market trading.
Sprinklr Reaffirms Q4, FY22 Guidance
Sprinklr (NYSE:CXM), the unified customer experience management (Unified-CXM) plat
Piper Sandler Maintains Overweight on Alteryx, Lowers Price Target to $85
Piper Sandler analyst Brent Bracelin maintains Alteryx (NYSE:AYX) with a Overweight and lowers the price target from $105 to $85.
Alteryx Announces Acquisition Of Trifacta For $400M
Alteryx, Inc. (NYSE:AYX), the Analytics Automation company, today announced it has entered into a definitive agreement to acquire Trifacta, an award-winning cloud company that leverages scalable data management and